Quest Diagnostics Inc Stock Research

Market Summary

USD133.77+1.08

Market Closed

0.81%

DGX Alerts

Big fall in Revenue (Y/Y)
Big fall in earnings (Y/Y)

DGX Stock Price

DGX RSI Chart

DGX Valuation

Market Cap

15.0B

Price/Earnings (Trailing)

18.89

Price/Sales (Trailing)

1.56

EV/EBITDA

13.79

Price/Free Cashflow

17.34

DGX Price/Sales (Trailing)

DGX Profitability

Operating Margin

34.74%

EBT Margin

12.50%

Return on Equity

16.05%

Return on Assets

7.37%

Free Cashflow Yield

5.77%

DGX Fundamentals

DGX Revenue

Revenue (TTM)

9.6B

Revenue Y/Y

-10.72%

Revenue Q/Q

-0.09%

DGX Earnings

Earnings (TTM)

793.0M

Earnings Y/Y

-43.1%

Earnings Q/Q

100%

Price Action

52 Week Range

119.75158.34

(Low)(High)

Last 7 days

1.7%

Last 30 days

-8.9%

Last 90 days

-4.4%

Trailing 12 Months

-4.6%

DGX Financial Health

Current Ratio

1.22

Debt/Equity

0.68

Debt/Cashflow

0.43

DGX Investor Care

Buy Backs (1Y)

5.88%

Diluted EPS (TTM)

6.83

Peers (Alternatives to Quest Diagnostics)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
HCA	73.0B	60.9B	-4.91%	25.24%	12.73	1.2	1.94%	-15.77%
LH	20.7B	14.8B	-2.77%	-13.32%	16.22	1.39	-6.96%	-52.35%
DGX	15.0B	9.6B	-8.90%	-4.59%	18.89	1.56	-10.08%	-57.84%
MID-CAP
UHS	9.9B	13.6B	-10.37%	3.84%	14.64	0.74	5.04%	-26.87%
EHC	6.1B	4.4B	-5.92%	18.26%	22.47	1.4	8.15%	-30.89%
LHCG	5.2B	2.3B	3.17%	35.63%	86.23	2.28	2.85%	-58.05%
ENSG	5.0B	3.2B	-11.17%	9.89%	21.14	1.55	17.88%	19.62%
AMN	3.9B	4.8B	11.84%	2.65%	10.12	0.8	3.57%	-4.88%
GH	2.9B	482.2M	34.10%	-27.10%	-4.41	5.98	23.29%	-70.12%
AMED	2.5B	2.2B	0.86%	-34.14%	22.43	1.13	0.55%	-41.23%
SMALL-CAP
RDNT	1.7B	1.5B	6.01%	44.82%	-126.07	1.14	10.24%	-173.11%
BKD	645.6M	2.9B	-18.53%	-39.08%	-3.53	0.22	7.97%	-101.02%
ENZ	111.6M	81.1M	-7.29%	3.62%	-3.17	1.38	-31.36%	-11847.33%
XGN	52.2M	46.4M	22.05%	-38.86%	-1.16	1.12	-3.55%	-44.93%
PMD	28.0M	25.2M	-8.89%	-21.14%	-25.78	1.11	1.33%	-63.01%

Financials for Quest Diagnostics

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	-2.8%	9,603	9,883	10,294	10,582	10,679
Cost Of Revenue	-1.3%	6,364	6,450	6,593	6,645	6,599
S&GA Expenses	0.7%	1,888	1,874	1,775	1,738	1,745
Costs and Expenses	-0.9%	8,383	8,455	8,465	8,493	8,445
EBITDA	-19.8%	1,534	1,912	2,203	2,688	-
EBITDA Margin	-16.4%	0.16*	0.19*	0.21*	0.25*	-
Earnings Before Taxes	-14.2%	1,060	1,235	1,628	1,931	2,425
EBT Margin	-21.0%	0.12*	0.16*	0.18*	0.23*	-
Interest Expenses	1.4%	-136	-138	-143	-148	-150
Net Income	-16.2%	793	946	1,235	1,484	1,881
Net Income Margin	-20.2%	0.10*	0.12*	0.14*	0.18*	-
Free Cahsflow	-10.2%	1,314	1,464	1,552	1,602	-

Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	-0.3%	12,794	12,837	13,223	13,312	13,442
Current Assets	-4.4%	1,814	1,898	2,334	2,426	2,475
Cash Equivalents	-44.4%	175	315	700	790	712
Inventory	-1.0%	190	192	183	187	197
Net PPE	1.6%	1,795	1,766	1,707	1,664	1,668
Goodwill	0.3%	7,241	7,220	7,190	7,195	7,197
Current Liabilities	-12.6%	1,355	1,551	1,602	1,577	1,700
Long Term Debt	-0.1%	3,975	3,978	3,980	3,983	3,985
LT Debt, Current	0%	2.00	2.00	2.00	2.00	2.00
Shareholder's Equity	2.7%	6,050	5,893	6,235	6,450	6,415
Retained Earnings	1.5%	8,412	8,290	8,263	8,083	7,926
Additional Paid-In Capital	-1.3%	2,266	2,295	2,272	2,250	2,226
Shares Outstanding	-3.4%	112	116	117	119	-
Minority Interest	2.7%	38.00	37.00	37.00	39.00	38.00

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	-22.5%	1,332	1,718	1,865	1,924	1,982
Share Based Compensation	7.8%	83.00	77.00	74.00	77.00	79.00
Cashflow From Investing	2.0%	-532	-543	-596	-574	-55.00
Cashflow From Financing	22.8%	-1,337	-1,732	-1,556	-1,120	-2,445
Dividend Payments	0%	305	305	307	305	308
Buy Backs	-26.5%	1,035	1,408	1,236	862	2,162

Risks for DGX

What is the probability of a big loss on DGX?

58.5%

Probability that Quest Diagnostics stock will be more than 20% underwater in next one year

19.2%

Probability that Quest Diagnostics stock will be more than 30% underwater in next one year.

Probability that Quest Diagnostics stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does DGX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Quest Diagnostics was unfortunately bought at previous high price.

Drawdowns

Returns for DGX

Cumulative Returns on DGX

10.0%

10-Year Cumulative Returns

10.2%

7-Year Cumulative Returns

6.7%

5-Year Cumulative Returns

7.6%

3-Year Cumulative Returns

What are the long-term rolling returns for DGX?

FIve years rolling returns for Quest Diagnostics.

Annualized Returns

Which funds bought or sold DGX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-23	Brookfield Corp /ON/	added	31.47	1,068,140	6,721,570	0.03%
2023-05-23	MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID	unchanged	-	-51,612	488,106	0.04%
2023-05-23	Front Row Advisors LLC	unchanged	-	-2,000	19,000	0.01%
2023-05-23	Toroso Investments, LLC	added	21.96	88,000	954,000	0.02%
2023-05-22	AMERIPRISE FINANCIAL INC	reduced	-11.54	-29,214,500	116,864,000	0.04%
2023-05-22	PUTNAM INVESTMENTS LLC	reduced	-22.68	-126,746	294,703	-%
2023-05-22	FDx Advisors, Inc.	unchanged	-	-	1,682,000	0.07%
2023-05-22	Raleigh Capital Management Inc.	added	23.72	2,848	27,282	0.01%
2023-05-18	JPMORGAN CHASE & CO	added	379	158,778,000	206,310,000	0.03%
2023-05-18	SkyView Investment Advisors, LLC	new	-	-	-	-%

Latest Funds Activity

Are funds buying DGX calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own DGX

No. of Funds

Quest Diagnostics News

Schedule 13G FIlings of Quest Diagnostics

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2023	vanguard group inc	12.27%	13,973,339	SC 13G/A
Feb 07, 2023	state street corp	5.16%	5,879,980	SC 13G/A
Jan 23, 2023	blackrock inc.	10.9%	12,391,327	SC 13G/A
Apr 08, 2022	blackrock inc.	10.7%	12,807,624	SC 13G/A
Feb 10, 2022	state street corp	5.11%	6,268,789	SC 13G
Feb 07, 2022	blackrock inc.	9.5%	11,636,382	SC 13G/A
Feb 10, 2021	vanguard group inc	10.64%	14,337,685	SC 13G/A
Feb 01, 2021	blackrock inc.	8.5%	11,464,215	SC 13G/A
Feb 13, 2020	macquarie group ltd	0.20%	271,969	SC 13G/A
Feb 12, 2020	vanguard group inc	11.42%	15,394,930	SC 13G/A

DGX Fair Value

Quest Diagnostics fair value in different scenarios

The table shows the Fair Value estimates for Quest Diagnostics for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	78.11 -41.61%	101.69 -23.98%	129.15 -3.45%	225.86 68.84%	311.56 132.91%
Current Inflation	72.87 -45.53%	93.46 -30.13%	116.75 -12.72%	198.93 48.71%	271.32 102.83%
Very High Inflation	66.25 -50.47%	83.29 -37.74%	101.79 -23.91%	167.42 25.16%	224.78 68.03%

Historical Quest Diagnostics Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of Quest Diagnostics

View All Filings

Date Filed	Form Type	Document
May 19, 2023	3	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading
May 19, 2023	4	Insider Trading

Latest Insider Trading transactions for DGX

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-17	MAIN TIMOTHY L	acquired	-	-	1,369	-
2023-05-17	Gregg Vicky B	acquired	-	-	1,369	-
2023-05-17	Doi Tracey	acquired	-	-	1,369	-
2023-05-17	RING TIMOTHY M	acquired	-	-	1,369	-
2023-05-17	Lassiter Wright III	acquired	-	-	1,369	-
2023-05-17	MORRISON DENISE M	acquired	-	-	1,369	-
2023-05-17	Diaz Luis	acquired	-	-	1,369	-
2023-05-17	WILENSKY GAIL R	acquired	-	-	1,369	-
2023-05-17	PFEIFFER GARY M	acquired	-	-	1,369	-
2023-04-24	KUPPUSAMY KARTHIK	acquired	3,576	143	25.00	svp, clinical solutions

About Quest Diagnostics

Stephen H. Rusckowski

www.questdiagnostics.com

49000

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

DGX Income Statement

2023-03-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net revenues	$ 2,331	$ 2,611
Operating costs and expenses and other operating income:
Cost of services	1,560	1,646
Selling, general and administrative	439	425
Amortization of intangible assets	26	27
Other operating expense, net	1	0
Total operating costs and expenses, net	2,026	2,098
Operating income	305	513
Other income (expense):
Interest expense, net	(35)	(37)
Other income (expense), net	7	(24)
Total non-operating expense, net	(28)	(61)
Income before income taxes and equity in earnings of equity method investees	277	452
Income tax expense	(65)	(110)
Equity in earnings of equity method investees, net of taxes	5	31
Net income	217	373
Less: Net income attributable to noncontrolling interests	15	18
Net income attributable to Quest Diagnostics	$ 202	$ 355
Earnings per share attributable to Quest Diagnostics’ common stockholders:
Basic (in dollars per share)	$ 1.80	$ 2.97
Diluted (in dollars per share)	$ 1.78	$ 2.92
Weighted average common shares outstanding:
Basic (in Shares)	112	119
Diluted (in Shares)	113	121

DGX Balance Sheet

2023-03-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 175	$ 315
Accounts receivable, net of allowance for credit losses of $30 as of both March 31, 2023 and December 31, 2022	1,254	1,195
Inventories	190	192
Prepaid expenses and other current assets	195	196
Total current assets	1,814	1,898
Property, plant and equipment, net	1,795	1,766
Operating lease right-of-use assets	589	585
Goodwill	7,241	7,220
Intangible assets, net	1,077	1,092
Investments in equity method investees	128	132
Other assets	150	144
Total assets	12,794	12,837
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	1,198	1,396
Current portion of long-term debt	2	2
Current portion of long-term operating lease liabilities	155	153
Total current liabilities	1,355	1,551
Long-term debt	3,975	3,978
Long-term operating lease liabilities	490	489
Other liabilities	809	812
Commitments and contingencies
Redeemable noncontrolling interest	77	77
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2023 and December 31, 2022; 162 shares issued as of both March 31, 2023 and December 31, 2022	2	2
Additional paid-in capital	2,266	2,295
Retained earnings	8,412	8,290
Accumulated other comprehensive loss	(18)	(21)
Treasury stock, at cost; 50 and 51 shares as of March 31, 2023 and December 31, 2022, respectively	(4,612)	(4,673)
Total Quest Diagnostics stockholders' equity	6,050	5,893
Noncontrolling interests	38	37
Total stockholders' equity	6,088	5,930
Total liabilities and stockholders' equity	$ 12,794	$ 12,837